Eupraxia Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	426	381	112	111	58	28
Market Cap Growth	170.04%	241.41%	0.65%	90.50%	111.19%	-
Enterprise Value	320	322	102	96	43	8
Last Close Price	6.52	7.55	3.17	4.16	2.69	2.30
PB Ratio	3.13	4.74	3.51	124.32	8.08	1.83
P/TBV Ratio	3.95	7.29	65.70	50.06	7.48	1.75
Debt / Equity Ratio	0.02	0.00	0.00	11.71	1.25	0.52
Net Debt / Equity Ratio	-1.00	-1.00	-1.04	-9.96	-1.29	-1.04
Net Debt / EBITDA Ratio	2.91	2.10	1.23	0.32	0.53	1.12
Net Debt / FCF Ratio	4.09	2.76	1.10	0.43	0.63	1.31
Quick Ratio	18.95	14.44	10.74	1.01	6.00	13.38
Current Ratio	19.30	15.12	11.10	1.02	6.08	13.49
Return on Equity (ROE)	-54.52%	-68.76%	-157.31%	-715.19%	-178.04%	-
Return on Assets (ROA)	-33.84%	-39.67%	-61.14%	-88.37%	-52.20%	-68.51%
Return on Capital Employed (ROCE)	-34.30%	-47.70%	-84.80%	-3120.70%	-109.70%	-61.90%
Earnings Yield	-11.02%	-10.12%	-22.84%	-25.44%	-31.75%	-68.66%
FCF Yield	-7.84%	-7.64%	-26.96%	-18.77%	-25.12%	-43.73%
Buyback Yield / Dilution	-26.83%	-17.76%	-40.52%	-25.21%	-55.45%	-102.75%

SEC Filings: 10-K · 10-Q